신종인플루엔자 대유행에 대한 백신 대응 전략
Vaccine Strategy for Influenza A (H1N1) Pandemic
2
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
Four months have passed since the World Health Organization declared worldwide pandemic by the novel influenza A (H1N1) virus, but the incidence rate does not seem to dwindle and each day we are faced with news from all around the world on death by this troublesome virus. Pandemic influenza vaccine is considered one of the most effective countermeasures for protecting susceptible individuals. However, it is envisaged that production of sufficient vaccine within an ideal timeframe will not be feasible, and thus, vaccine supply is expected to fall short of demand. Therefore, it is mandatory to establish a proper vaccine strategy for maximizing the effect of pandemic influenza vaccine. In this article, we have described many critical points that should be taken into consideration when establishing pandemic vaccine strategies based on the newest data and the strategies adopted by other countries.
Abstract
Four months have passed since the World Health Organization declared worldwide pandemic by the novel influenza A (H1N1) virus, but the incidence rate does not seem to dwindle and each day we are faced with news from all around the world on death by this troublesome virus. Pandemic influenza vaccine is considered one of the most effective countermeasures for protecting susceptible individuals. However, it is envisaged that production of sufficient vaccine within an ideal timeframe will not be feasible, and thus, vaccine supply is expected to fall short of demand. Therefore, it is mandatory to establish a proper vaccine strategy for maximizing the effect of pandemic influenza vaccine. In this article, we have described many critical points that should be taken into consideration when establishing pandemic vaccine strategies based on the newest data and the strategies adopted by other countries.
참고문헌 (31)
- Pandemic (H1N1) 2009 briefing note 1 Viruses resistant to oseltamivir (Tamiflu) identified, "Wkly Epidemiol Rec 84:299-399, 2009", ~
- Centers for Disease Control and Prevention (CDC), "Oseltamivir-resistant novel influenza A (H1N1) virus infection in two immunosuppressed patients - Seattle, Washington, 2009", MMWR Morb Mortal Wkly Rep, 58, pp.893~896 (2009)
- Duwe S, "Person-to-person transmission of oseltamivir- resistant influenza A", H1N1 viruses in two households; Germany 2007, J Clin Virol, pp.2009, 46[DOI]
- Leung TW, "Detection of an oseltamivir-resistant pandemic influenza A", H1N1 virus in Hong Kong, 2009, pp.46, 298~299
- Centers for Disease Control and Prevention (CDC), "Oseltamivir-resistant 2009 pandemic influenza A (H1N1) virus infection in two summer campers receiving prophylaxis--North Carolina, 2009", MMWR Morb Mortal Wkly Rep, 58, pp.969~972 (2009)
- Collin N, "World Health Organization H1N1 Vaccine Task Force", Vaccine, 27, pp.5184~5186 (2009)
- "World Health Organization"[URL]
- "U.S. Department of Health & Human Services"[URL]
- "Department of Health"[URL]
- "Xinhuanet"[URL]
- "YOMIURI ONLINE/URL:"[URL]
- Use of influenza A (H1N1) 2009 monovalent vaccine: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2009, "MMWR Recomm Rep 58:1-8, 2009", ~
- "ECDC Interim guidance: use of specific pandemic influenza vaccines during the H1N1 2009 pandemic"[URL]
- "Xinhuanet"[URL]
- Mylius SD, "Optimal allocation of pandemic influenza vaccine depends on age, risk and timing", Vaccine, 26, pp.3742~3749 (2008)
- El Sahly HM, "Pandemic H5N1 influenza vaccine development: an update", Expert Rev Vaccines, 7, pp.241~247 (2008)
- Greenberg ME, "Response after One Dose of a Monovalent Influenza A (H1N1) 2009 Vaccine -- Preliminary Report", N Engl J Med (2009)
- Clark TW, "Trial of Influenza A (H1N1) 2009 Monovalent MF59-Adjuvanted Vaccine -- Preliminary Report", N Engl J Med (2009)
- "Thomson Reuters"[URL]
- Evans D, ""Prepandemic" immunization for novel influenza viruses, "swine flu" vaccine, Guillain-Barré syndrome, and the detection of rare severe adverse events", J Infect Dis, 200, pp.321~328 (2009)
- Lasky T, "The Guillain-Barré syndrome and the 1992-1993 and 1993-1994 influenza vaccines", N Engl J Med, 339, pp.1797~1802 (1998)